EPCAM and neoplasm: More recently, we have studied the expression of five different BCSC markers (CD44, integrin subunit α6, cadherin-3, EpCAM, and ALDH1) and found significant enrichment for each biomarker in human breast cancer brain metastasis when compared with unmatched primary tumours.